Trial Outcomes & Findings for Cranberry Effect on Urinary Tract Infections (NCT NCT02996981)
NCT ID: NCT02996981
Last Updated: 2023-08-31
Results Overview
Recruitment status
COMPLETED
Target enrollment
167 participants
Primary outcome timeframe
within 6 weeks postoperative
Results posted on
2023-08-31
Participant Flow
Participant milestones
| Measure |
Cranberry Group
Patients underwent pelvic floor gynecologic surgery performed by a physician at Cincinnati Urogynecology Associates, TriHealth Inc between April 2016 and September 2016 and discharged home with an indwelling urinary catheter following the surgery. This group of people had cranberry juice capsules prescribed.
|
No Cranberry Group
Patients underwent pelvic floor gynecologic surgery performed by a physician at Cincinnati Urogynecology Associates, TriHealth Inc between April 2015 and September 2015. This group of people did not have cranberry juice capsules prescribed.
|
|---|---|---|
|
Overall Study
STARTED
|
96
|
71
|
|
Overall Study
COMPLETED
|
96
|
71
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Cranberry Effect on Urinary Tract Infections
Baseline characteristics by cohort
| Measure |
Cranberry Group
n=96 Participants
Patients underwent pelvic floor gynecologic surgery performed by a physician at Cincinnati Urogynecology Associates, TriHealth Inc between April 2016 and September 2016 and discharged home with an indwelling urinary catheter following the surgery. This group of people had cranberry juice capsules prescribed.
|
No Cranberry Group
n=71 Participants
Patients underwent pelvic floor gynecologic surgery performed by a physician at Cincinnati Urogynecology Associates, TriHealth Inc between April 2015 and September 2015. This group of people did not have cranberry juice capsules prescribed.
|
Total
n=167 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
60.28 years
STANDARD_DEVIATION 14.10 • n=39 Participants
|
59.62 years
STANDARD_DEVIATION 15.29 • n=41 Participants
|
60.00 years
STANDARD_DEVIATION 14.57 • n=35 Participants
|
|
Sex: Female, Male
Female
|
96 Participants
n=39 Participants
|
71 Participants
n=41 Participants
|
167 Participants
n=35 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=39 Participants
|
0 Participants
n=41 Participants
|
0 Participants
n=35 Participants
|
|
Race/Ethnicity, Customized
White
|
86 Participants
n=39 Participants
|
64 Participants
n=41 Participants
|
150 Participants
n=35 Participants
|
|
Race/Ethnicity, Customized
African American
|
6 Participants
n=39 Participants
|
4 Participants
n=41 Participants
|
10 Participants
n=35 Participants
|
|
Race/Ethnicity, Customized
Asian
|
1 Participants
n=39 Participants
|
1 Participants
n=41 Participants
|
2 Participants
n=35 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
3 Participants
n=39 Participants
|
0 Participants
n=41 Participants
|
3 Participants
n=35 Participants
|
|
Race/Ethnicity, Customized
Other
|
0 Participants
n=39 Participants
|
2 Participants
n=41 Participants
|
2 Participants
n=35 Participants
|
|
Region of Enrollment
United States
|
96 participants
n=39 Participants
|
71 participants
n=41 Participants
|
167 participants
n=35 Participants
|
PRIMARY outcome
Timeframe: within 6 weeks postoperativeOutcome measures
| Measure |
Cranberry Group
n=96 Participants
Patients underwent pelvic floor gynecologic surgery performed by a physician at Cincinnati Urogynecology Associates, TriHealth Inc between April 2016 and September 2016 and discharged home with an indwelling urinary catheter following the surgery. This group of people had cranberry juice capsules prescribed.
|
No Cranberry Group
n=71 Participants
Patients underwent pelvic floor gynecologic surgery performed by a physician at Cincinnati Urogynecology Associates, TriHealth Inc between April 2015 and September 2015. This group of people did not have cranberry juice capsules prescribed.
|
|---|---|---|
|
The Incidence of UTI
|
66 Participants
|
54 Participants
|
Adverse Events
Cranberry Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
No Cranberry Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place